BRIEF Bendamustine and Rituximab In Elderly Follicular
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Follicular Lymphoma
Related studies linked through entity extraction aliases.
Safety and Efficacy Study of Idelalisib (GS-1101, CAL-101) in Patients With Previously Treated Low-grade Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
A Trial Looking at Rituximab and Chemotherapy as a Treatment for Follicular Lymphoma in Elderly Patients
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas
- Status
- COMPLETED
- Phase
- PHASE2
Study of HCD122 (Lucatumumab) and Bendamustine Combination Therapy in CD40+ Rituximab-refractory Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Ofatumumab for Initial Systemic Treatment of Indolent B-cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Lenalidomide Therapy In Previously Untreated, Advanced Stage Follicular Lymphoma
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
T-Regulatory Cell and CD3 Depleted Double Umbilical Cord Blood Transplantation in Hematologic Malignancies
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
Evaluation of Patient and Lesion Specific Prognostic Factors for Standard Radioimmunotherapy
- Status
- UNKNOWN
- Phase
- N/A
Combination Veltuzumab and Fractionated 90Y- Epratuzumab Radioimmunotherapy in Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Immunochemotherapy, Zevalin, and Bone Marrow Transplant for Follicular Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Epigenetic Modulation in Relapsed/Refractory Follicular Lymphoma and Marginal Zone Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2
First in Human Study to Determine the Safety, Tolerability and Preliminary Efficacy of an Anti-CXCR4 Antibody in Subjects With Acute Myelogenous Leukemia and Selected B-cell Cancers
- Status
- COMPLETED
- Phase
- PHASE1
Study of SyB L-0501 in Combination With Rituximab to Treat Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability Study of PCI-32765 in B Cell Lymphoma and Chronic Lymphocytic Leukemia
- Status
- COMPLETED
- Phase
- PHASE2
Temsirolimus, Bendamustine and Rituximab for Relapsed Follicular Lymphoma or Mantle Cell Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Bortezomib and Vorinostat as Maintenance Therapy After Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Repeat Intranodal Injections of Ad-ISF35
- Status
- TERMINATED
- Phase
- PHASE2
Prospective Multicenter Dose Finding Phase II Pilot Trial to Evaluate Efficacy and Safety of LR-CHOP21 for Elderly Patients With Untreated Diffuse Large B Cell Lymphoma
- Status
- UNKNOWN
- Phase
- PHASE2
Bendamustine, Mitoxantrone, and Rituximab (BMR) for Patients With Untreated High Risk Follicular Lymphoma
- Status
- TERMINATED
- Phase
- PHASE2